INOZYME PHARMA, INC. Interest Paid, Excluding Capitalized Interest, Operating Activities
INOZYME PHARMA, INC. reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $4.35 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2025-03-10
- INOZYME PHARMA, INC. interest paid, excluding capitalized interest, operating activities for fiscal 2024 was $4.35M, a 85.34% increase from fiscal 2023.
- INOZYME PHARMA, INC. interest paid, excluding capitalized interest, operating activities for fiscal 2023 was $2.35M, a 1280.59% increase from fiscal 2022.
- INOZYME PHARMA, INC. interest paid, excluding capitalized interest, operating activities for fiscal 2022 was $170.00K.
- INOZYME PHARMA, INC. interest paid, excluding capitalized interest, operating activities for fiscal 2021 was $0.00.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|
| 2024-12-31 | $4.35M 10-K · filed 2025-03-10 |
| 2023-12-31 | $2.35M 10-K · filed 2025-03-10 |
| 2022-12-31 | $170.00K 10-K · filed 2024-03-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-22 |